Literature DB >> 20477353

Lung disease at high altitude.

Joshua O Stream1, Andrew M Luks, Colin K Grissom.   

Abstract

Large numbers of people travel to high altitudes, entering an environment of hypobaric hypoxia. Exposure to low oxygen tension leads to a series of important physiologic responses that allow individuals to tolerate these hypoxic conditions. However, in some cases hypoxia triggers maladaptive responses that lead to various forms of acute and chronic high altitude illness, such as high-altitude pulmonary edema or chronic mountain sickness. Because the respiratory system plays a critical role in these adaptive and maladaptive responses, patients with underlying lung disease may be at increased risk for complications in this environment and warrant careful evaluation before any planned sojourn to higher altitudes. In this review, we describe respiratory disorders that occur with both acute and chronic exposures to high altitudes. These disorders may occur in any individual who ascends to high altitude, regardless of his/her baseline pulmonary status. We then consider the safety of high-altitude travel in patients with various forms of underlying lung disease. The available data regarding how these patients fare in hypoxic conditions are reviewed, and recommendations are provided for management prior to and during the planned sojourn.

Entities:  

Year:  2009        PMID: 20477353      PMCID: PMC4798974          DOI: 10.1586/ers.09.51

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  190 in total

1.  Neck irradiation or surgery may predispose to severe acute mountain sickness.

Authors:  Buddha Basnyat
Journal:  J Travel Med       Date:  2002 Mar-Apr       Impact factor: 8.490

2.  Abnormal control of ventilation in high-altitude pulmonary edema.

Authors:  P H Hackett; R C Roach; R B Schoene; G L Harrison; W J Mills
Journal:  J Appl Physiol (1985)       Date:  1988-03

3.  Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.

Authors:  Marco Maggiorini; Hans-Peter Brunner-La Rocca; Simon Peth; Manuel Fischler; Thomas Böhm; Alain Bernheim; Stefanie Kiencke; Konrad E Bloch; Christoph Dehnert; Robert Naeije; Thomas Lehmann; Peter Bärtsch; Heimo Mairbäurl
Journal:  Ann Intern Med       Date:  2006-10-03       Impact factor: 25.391

4.  Exercise-induced bronchospasm among healthy elite cross country skiers and non-athletic students.

Authors:  H Pohjantähti; J Laitinen; J Parkkari
Journal:  Scand J Med Sci Sports       Date:  2005-10       Impact factor: 4.221

5.  Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema.

Authors:  E Hohenhaus; A Paul; R E McCullough; H Kücherer; P Bärtsch
Journal:  Eur Respir J       Date:  1995-11       Impact factor: 16.671

6.  Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude.

Authors:  C C Christensen; M Ryg; O K Refvem; O H Skjønsberg
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

7.  Activation of coagulation system during air travel: a crossover study.

Authors:  A J M Schreijer; S C Cannegieter; J C M Meijers; S Middeldorp; H R Büller; F R Rosendaal
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

8.  Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function.

Authors:  A J Finnimore; R V Jackson; A Morton; E Lynch
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

9.  Ventilatory response in myotonic dystrophy.

Authors:  J E Carroll; C W Zwillich; J V Weil
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

10.  Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats.

Authors:  John T Berg; S Ramanathan; Erik R Swenson
Journal:  Wilderness Environ Med       Date:  2004       Impact factor: 1.518

View more
  11 in total

1.  The protective role of 5-hydroxymethyl-2-furfural (5-HMF) against acute hypobaric hypoxia.

Authors:  Ming-Ming Li; Li-Ying Wu; Tong Zhao; Kui-Wu Wu; Lei Xiong; Ling-Ling Zhu; Ming Fan
Journal:  Cell Stress Chaperones       Date:  2011-04-15       Impact factor: 3.667

2.  How Do COVID-19 Inpatients in the Denver Metropolitan Area Measure Up?

Authors:  Paula J Watts; Trevor Wojcik; Christina Baker-Sparr; Jason L Kelly; Surit Sharma; Dmitriy Scherbak
Journal:  Adv Med       Date:  2020-10-28

Review 3.  Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment.

Authors:  Kirsten Holthof; Pierre-Olivier Bridevaux; Isabelle Frésard
Journal:  BMC Pulm Med       Date:  2022-05-09       Impact factor: 3.320

4.  Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities.

Authors:  Sean M Hacking
Journal:  Med Hypotheses       Date:  2020-09-02       Impact factor: 1.538

5.  Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration.

Authors:  Michal Shteinberg; Barbara Crossley; Tal Lavie; Sima Nadler; Jeanette Boyd; Felix C Ringshausen; Tim Aksamit; James D Chalmers; Pieter Goeminne
Journal:  ERJ Open Res       Date:  2019-10-30

6.  Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass.

Authors:  Yadira Velasco-Torres; Víctor Ruiz; Martha Montaño; Rogelio Pérez-Padilla; Ramcés Falfán-Valencia; Julia Pérez-Ramos; Oliver Pérez-Bautista; Carlos Ramos
Journal:  Biomolecules       Date:  2019-12-06

7.  Effect of Nocturnal Oxygen on Blood Pressure Response to Altitude Exposure in COPD - Data from a Randomized Placebo-Controlled Cross-Over Trial.

Authors:  Martina Meszaros; Tsogyal D Latshang; Sayaka S Aeschbacher; Fabienne Huber; Deborah Flueck; Mona Lichtblau; Stefanie Ulrich; Elisabeth D Hasler; Philipp M Scheiwiller; Lukas Reinhard; Silvia Ulrich; Konrad E Bloch; Michael Furian; Esther I Schwarz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-24

8.  Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.

Authors:  Michael H Cho; Brian D Hobbs; Jingzhou Zhang; Dawn L DeMeo; Edwin K Silverman; Barry J Make; R Chad Wade; J Michael Wells
Journal:  BMC Pulm Med       Date:  2021-07-14       Impact factor: 3.320

9.  The lung at high altitude.

Authors:  Annalisa Cogo
Journal:  Multidiscip Respir Med       Date:  2011-02-28

10.  Determinants of Acute Respiratory Infection Among Children in Ethiopia: A Multilevel Analysis from Ethiopian Demographic and Health Survey.

Authors:  Zelalem Alamrew Anteneh; Hamid Yimam Hassen
Journal:  Int J Gen Med       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.